Skip to main content
SpringerLink
Log in

A Method to Select an Instrument for Measurement of HR-QOL for Cross-Cultural Adaptation Applied to Dermatology

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Objective: The objective of this study was to develop a process to obtain an instrument to measure dermatology specific health-related quality of life (HRQOL), and to adapt it into another culture, namely the Spanish-speaking community

Design and Setting: By consensus, a multi-disciplinary team determined the qualities of an ‘ideal’ questionnaire as follows: need (absence of any such instrument), utility, multi-dimensionality, psychometric development, simplicity, high degree of standardisation, and accessibility.

A bibliographic search was conducted on Medline, EMBASE and IME (Spanish Medical Index), using ‘dermatology’ and ‘quality of life’ as the key words, from January 1990 through to September 1997, supplemented by a second level reference search, to identify the instruments already in existence. Rather than develop a questionnaire ex novo, it was decided to make a cultural adaptation of an existing one. The questionnaires identified in the literature search were classified according to their generic or specific scope and it was decided to adapt a dermatology specific instrument. To select and compare the instruments, a model was developed which would provide an Adaptation Index (ADAPT), which includes the degree of development of psychometric properties, the formal design and the degree of standardisation at a given moment in time.

Results: Six dermatology specific scales were identified: Impact of Skin Disease Scale (IMPACT), Dermatology Life Quality Index (DLQI), Skindex, Dermatology Quality-of-Life Scales (DQOLS), Dermatology Specific Quality of Life (DSQL) and Qualita di Vita Italiana in Dermatologia (QUAVIDERM). The ADAPT Index for each of the above was determined at the time of the study and the DLQI was chosen for adaptation (ADAPT = 77, October 1997).

Results: Six dermatology specific scales were identified: Impact of Skin Disease Scale (IMPACT), Dermatology Life Quality Index (DLQI), Skindex, Dermatology Quality-of-Life Scales (DQOLS), Dermatology Specific Quality of Life (DSQL) and Qualita di Vita Italiana in Dermatologia (QUAVIDERM). The ADAPT Index for each of the above was determined at the time of the study and the DLQI was chosen for adaptation (ADAPT = 77, October 1997).

Conclusions: The study showed the utility of ADAPT Index to assist in the selection process of the questionnaire to adapt. The results of the analysis indicate that in order to introduce and systematically use dermatology specific HR-QOL instruments, the indices require consolidation and improvement. There is a special need for an effort to be made in developing transculturally equivalent instruments suitable for international research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jowett S, Ryan T. Skin disease and handicap: an analysis of theimpact of skin conditions. Soc Sci Med 1985; 20: 425–9

    Article  PubMed  CAS  Google Scholar 

  2. Finlay AY, Ryan TJ. Disability and handicap in dermatology. IntJ Dermatol 1996; 35(5): 305–11

    Article  CAS  Google Scholar 

  3. Ramsey B, O’Regan M. A survey of the social and psychologicaleffects of psoriasis. Br J Dermatol 1988; 118: 195–201

    Article  Google Scholar 

  4. Long CC, Funnell CM, Collard R, et al. What do members ofthe National Eczema Society really want? Clin Exp Dermatol1993; 18: 516–22

    Article  PubMed  CAS  Google Scholar 

  5. Rajagopalan R, Anderson RT. The profile of a patient with contactdermatitis and a suspicion of contact allergy (history,physical characteristics, and dermatology-specific quality oflife). Am J Contact Dermatitis 1997; 8(1): 26–31

    Article  PubMed  CAS  Google Scholar 

  6. Simpson N.Effect of isotretinoin on quality of life in patientswith acne. Pharmacoeconomics 1994; 6(2): 108–13

    Article  PubMed  CAS  Google Scholar 

  7. O’DonnellBFLawlorFSimpsonJetal.Theimpactofchronicurticariaonthequalityoflife.BrJDermatol1997;1362197–20

    Article  PubMed  Google Scholar 

  8. Klyscz T, Shanz S, Janz M, et al. Quality of life and coping withdisease in patients with chronic venous insufficiency.Phlebologie 1996; 25(6): 239–44

    Google Scholar 

  9. Tebbe B, Orfanos C. Epidemiology and socioeconomic impactof skin disease in lupus erythematosus. Lupus 1997; 6(2):96–104

    Article  PubMed  CAS  Google Scholar 

  10. Lindholm C, Bjellerup M, Christensen OB. Quality of life inchronic leg ulcers patients. Acta Derm Venereol Suppl(Stockh) 1993; 73: 440–3

    CAS  Google Scholar 

  11. Lubeck DP, Patrick DL, McNulty P, et al. Quality of life ofperson with onychomycosis. Qual Life Res 1993; 2: 341–8

    Article  PubMed  CAS  Google Scholar 

  12. Van Der Donk J, Hunfeld JAM, Passchier J, et al. Quality of lifeand maladjustment associated with hair loss in women withalopecia androgenetica. Soc Sci Med 1994; 38: 159–63

  13. McKenna KE, Stern RS. The outcomes movement and newmeasures of the severity of psoriasis. J Am Acad Dermatol 1996; 34: 534–8

    Article  PubMed  CAS  Google Scholar 

  14. Mauskopf JA, Austin R, Dix LP, et al. Estimating the value ofa generic quality of life measure. Med Care 1995; 33(4):AS195–202

    PubMed  CAS  Google Scholar 

  15. Gª de Tiedra A, Mercadal J, Lozano R. Prednicarbate versusfluocortin for inflammatory dermatoses: a cost-effectivenessstudy. Pharmacoeconomics 1997; 12(2): 193–208

    Article  Google Scholar 

  16. Kurwa HA Finlay AY. Dermatology in-patient managementgreatly improves life quality. Br J Dermatol 1995; 133: 575–8

    Article  PubMed  CAS  Google Scholar 

  17. Berzon RA, Donnelly MA, Simpson RL, et al. Quality of lifebibliography and indexes: 1994 update. Qual Life Res 1995;4: 547–69

    Article  PubMed  CAS  Google Scholar 

  18. Katsambas A. Quality of life in dermatology and the EADV. JEur Acad Dermatol Venereol 1994; 3: 211–4

    Article  Google Scholar 

  19. Lisi P, Stingeni L, Benvenuti C, et al. QUAVIDERM: a questionnairefor the evaluation of the Italian quality if life indermatology. Ann Ital Dermatol Clin Sper 1997; 51(2): 39–44

    Google Scholar 

  20. Badía X, Salamero M, Alonso J, et al. La medida de la salud:guía de escalas de medición en español. Barcelona: Ed PPU,1997

    Google Scholar 

  21. Becker M.Quality-of-life instruments for severe chronic mentalillness: implications for pharmacotherapy. Pharmacoeconomics1995; 7(3): 229–37

    Article  PubMed  CAS  Google Scholar 

  22. Osoba D. Measuring the effect of cancer on health-related qualityof life. Pharmacoeconomics 1995; 7(4): 308–19

    Article  PubMed  CAS  Google Scholar 

  23. Guyatt GH, Sander JO, Feeny DH.Measuring quality of life inclinical trials: a taxonomy and review. Can Med Assoc J 1989;140: 1441–8

    CAS  Google Scholar 

  24. Finlay AY. Quality of life measurement in dermatology: a practicalguide. Br J Dermatol 1997; 136: 305–14

    Article  PubMed  CAS  Google Scholar 

  25. Testa MA, Simonson DC. Assessment of quality-of-life outcomes.N Engl J Med 1996; 334(13): 835–40

    Article  PubMed  CAS  Google Scholar 

  26. Berzon R, Hays RD, Shumaker SA. International use, applicationand performance of health-related quality of life instruments.Qual Life Res 1993; 2: 367–8

    Article  PubMed  CAS  Google Scholar 

  27. Hays RD, Anderson R, Revicki D. Psychometric considerationsin evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441–9

    Article  PubMed  CAS  Google Scholar 

  28. Grau G. Metodología para la validación de cuestionarios.Medifam 1995; 5(6): 351–9

    Google Scholar 

  29. Bisquerra R. Métodos de investigación educativa. Guíapráctica. Barcelona: CEAC 1989

    Google Scholar 

  30. Adaptación transcultural de cuestionarios en ciencias de lasalud [editorial]. Medifam 1997; 7(1): 1–4

    Google Scholar 

  31. de Boer JB, van Dam F, Sprangers M. Health-related qualityof-life evaluation in HIV-infected patients: a review of theliterature. Pharmacoeconomics 1995; 8(4): 291–304

    Article  PubMed  Google Scholar 

  32. McDowell I, Newell C. Measuring health: a guide to ratingscales and questionnaires. New York: Oxford UniversityPress, 1987

    Google Scholar 

  33. Streiner DL, Geoffrey NR. Health measurement scales: a practicalguide to their development and use. New York: OxfordUniversity Press, 1989

    Google Scholar 

  34. Williams HC. Is a simple generic index of dermatologic diseaseseverity an attainable goal? [editorial]. Arch Dermatol 1997;133: 1451–2

    Article  PubMed  CAS  Google Scholar 

  35. Hunt SM. Cross-cultural comparability of quality of life measures.Drug Inf J 1993; 27: 395–400

    Article  Google Scholar 

  36. Lewis-Jones MS, Finlay AY. The children’s dermatology lifequality index (CDLQI): initial validation and practical use.Br J Dermatol 1995; 132(6): 942–9

    Article  PubMed  CAS  Google Scholar 

  37. Wessely SC, Lewis GH. The classification of psychiatric morbidityin attenders at a dermatology clinic. Br J Psychiatry1989; 155: 686–91

    PubMed  CAS  Google Scholar 

  38. Finlay AY, Khan GK. Dermatology life quality index (DLQI):a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210–6

    Article  PubMed  CAS  Google Scholar 

  39. Bergner M, Bobbitt RA, Kressel S, et al. The sickness impactprofile: conceptual formulation and methodology for the developmentof a health status measure. Int J Health Serv 1976; 6(3): 393–415

    Article  PubMed  CAS  Google Scholar 

  40. Ware Jr J E, Sherbourne CD. The MOS 36-item short-formhealth survey (SF-36). I: conceptual framework and item selection. Med Care 1992; 30(6): 473–83

    Article  PubMed  Google Scholar 

  41. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979;9(1): 139–45

    Article  PubMed  CAS  Google Scholar 

  42. Hunt SM, McKenna SP, McEwen J, et al. A quantitative approachto perceived health status: a validation study. JEpidemiol Community Health 1980; 34(4): 281–6

    Article  CAS  Google Scholar 

  43. Ruta DA, Garratt AM, Leng M, et al. A new approach to themeasurement of quality of life: The Patient-Generated Index.Med Care 1994; 32(11): 1109–26

    Article  PubMed  CAS  Google Scholar 

  44. Ryan LS. Psychosocial issues and lung cancer: a behaviouralapproach. Semin Oncol Nurs 1996; 12(4): 318–23

    Article  PubMed  CAS  Google Scholar 

  45. Rauch PK, Jellinek MS, Murphy JM, et al. Screening for psychosocialdysfunction in pediatric dermatology practice. Clin Pediatr (Phila) 1991; 30(8): 493–7

    Article  CAS  Google Scholar 

  46. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: apreliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75(3): 240–3

    PubMed  CAS  Google Scholar 

  47. Motley RJ, Finlay AY. Practical use of a disability index in theroutine management of acne. Clin Exp Dermatol 1992; 17(1):1–3

    Article  PubMed  CAS  Google Scholar 

  48. Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology1997; 195 Suppl. 1: 15-21. Discussion no.: 38-40

    Google Scholar 

  49. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-oflifemeasure for patients with skin disease: reliability, validityand responsiveness. J Invest Dermatol 1996; 107(5): 707–13

    Article  PubMed  CAS  Google Scholar 

  50. Morgan M, McCreedy R, Simpson J, et al. Dermatology qualityof life scales: a measure of the impact of skin diseases. Br JDermatol 1997; 136(2): 202–6

    Article  CAS  Google Scholar 

  51. Anderson RT, Rajagopalan R. Development and validation ofa quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37(1): 41–50

    Article  PubMed  CAS  Google Scholar 

  52. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatlyimproves the quality of life of adults with severe atopic dermatitis:a randomized double-blind, placebo controlled trial.Br J Dermatol 1993; 129(4): 422–30

    Article  PubMed  CAS  Google Scholar 

  53. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sicknessimpact profile and psoriasis inability index in psoriasis.Br J Dermatol 1990; 123(6): 751–6

    Article  PubMed  CAS  Google Scholar 

  54. Finlay AY, Coles EC.The effect of severe psoriasis on the qualityof life of 369 patients. Br J Dermatol 1995; 132(2): 236–44

    Article  PubMed  CAS  Google Scholar 

  55. Fleischer Jr AB, Clark AR, Rapp SR, et al. Commercial tanningbed treatment is an effective psoriasis treatment: results froman uncontrolled clinical trial. J Invest Dermatol 1997; 109(2):170–4

    Article  PubMed  Google Scholar 

  56. Motley RJ, Finlay AY. How much disability is caused by acne?Clin Exp Dermatol 1991; 16: 371–3

    Article  Google Scholar 

  57. Salek MS, Khan GK, Finlay AY. Questionnaire techniques inassessing acne handicap: reliability and validity study. Qual Life Res 1996; 5(1): 131–8

    Article  PubMed  CAS  Google Scholar 

  58. Nichol MB, Margolies JE, Lippa E, et al. The application ofmultiple quality-of-life instruments in individuals with mildto-moderate psoriasis. Pharmacoeconomics 1996; 10(6):644–53

    Article  PubMed  CAS  Google Scholar 

  59. Kent G, Al-Abadie M. Factors affecting responses on dermatologylife quality index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330–3

    Article  PubMed  CAS  Google Scholar 

  60. Finlay AY. Measures of the effect of adult severe atopic eczemaon quality of life. J Eur Acad Dermatol Venereol 1996; 7(2):149–54

    Article  Google Scholar 

  61. Herd RM, Tidman MJ, Ruta DA, et al. Measurement of qualityof life in atopic dermatitis: correlation and validation of twodifferent methods. Br J Dermatol 1997; 136(4): 502–7

    Article  PubMed  CAS  Google Scholar 

  62. Blackford S, Finlay A, Roberts DL. Quality of life in Behçet’ssyndrome: 335 patients surveyed. Br J Dermatol 1997; 136(2): 277–99

    Article  Google Scholar 

  63. Harris A, Burge SM, Dykes PJ, et al. Handicap in Darier’s diseaseand Hailey-Hailey disease. Br J Dermatol 1996; 135:959–63

    Article  PubMed  CAS  Google Scholar 

  64. Kurwa H, Finlay AY. Dermatology in patient admission greatlyimproves life quality. Br J Dermatol 1995; 133: 575–8

    Article  PubMed  CAS  Google Scholar 

  65. Clark SM, Goulden V, Finlay AY, et al. The psychological andsocial impact of acne: a comparison study using three acnedisability questionnaires. Br J Dermatol 1997; Suppl. 50: 41

    Google Scholar 

  66. Blackford S, Roberts D, Salek MS, et al. Basal cell carcinomascause little handicap. Qual Life Res 1996; 5: 191–4

    Article  PubMed  CAS  Google Scholar 

  67. Newton JN, Mallon E, Klassen A, et al. The effectiveness ofacne treatment: an assessment by patients of the outcome oftherapy. Br J Dermatol 1997; 137: 563–7

    Article  PubMed  CAS  Google Scholar 

  68. Chren MM, Lasek RJ, Quinn LM, et al. Convergent and discriminantvalidity of a generic and a disease-specific instrumentto measure quality of life in patients with skin disease.J Invest Dermatol 1997; 108: 103–7

    Article  PubMed  CAS  Google Scholar 

  69. Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminativeand evaluative capability of a refined version of skindex,a quality-of-life instrument for patients with skin diseases.Arch Dermatol 1997; 133: 1433–40

    Article  PubMed  CAS  Google Scholar 

  70. Rajagopalan R, Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contactdermatitis. Am J Contact Dermatitis 1997; 8(4): 215–21

    Article  PubMed  CAS  Google Scholar 

  71. Lisi P, Stingeni L, Benvenuti C, et al. QUAVIDERM: a questionnairefor the evaluation of the Italian quality of life indermatology. Ann Ital Dermatol Clin Sper 1997; 51(12):39–44

    Google Scholar 

  72. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol 1987; 12: 8–11

    Article  CAS  Google Scholar 

  73. Kent G, Al-Abadie M. The psoriasis disability index: furtheranalyses. Clin Exp Dermatol 1993; 18: 414–6

    Article  PubMed  CAS  Google Scholar 

  74. Gupta MA, Gupta AK, Kirby S, et al. A psychocutaneous profileof psoriasis patients who are stress reactors. Gen Hosp Psychiatry1989; 11: 166–73

    Article  PubMed  CAS  Google Scholar 

  75. Juniper E. Quality-of-life considerations in the treatment ofasthma. Pharmacoeconomics 1995; 8(2): 123–38

    Article  PubMed  CAS  Google Scholar 

  76. Erickson P, Taeuber RC, Scott J.Operational aspects of qualityof-life assessment: choosing the right instrument. Pharmacoeconomics1995; 7(1): 39–48

    Article  PubMed  CAS  Google Scholar 

  77. Bullinger M, Anderson R, Cella D, et al. Developing and evaluatingcross-cultural instruments from minimum requirementsto optimal models. Qual Life Res 1993; 2: 451–9

    Article  PubMed  CAS  Google Scholar 

  78. Badía X. Sobre la adaptación transcultural de medidas de lacalidad de vida relacionada con la salud para su uso enEspaña. Med Clin (Barc) 1995; 105: 56–8

    Google Scholar 

  79. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptationof health-related quality of life measures: literature reviewand proposed guidelines. J Clin Epidemiol 1993; 46(12): 1417–32

    Article  PubMed  CAS  Google Scholar 

  80. Guyatt GH, Jaeschke RJ. Reassessing quality-of-life instrumentsin the evaluation of new drugs. Pharmacoeconomics1997; 12(6): 621–6

    Article  PubMed  CAS  Google Scholar 

  81. Wright JG, Feinstein AR. A comparative contrast of clinimetricand psychometric methods for constructing indexes and ratingscales. J Clin Epidemiol 1992; 45: 1201–18

    Article  PubMed  CAS  Google Scholar 

  82. Anderson RT, Aaronson NK, Bullinger M, et al. A review of theprogress towards developing health-related quality-of-life instrumentsfor international clinical studies and outcomes research.Pharmacoeconomics 1996; 10(4): 336–55

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, Laboratorios Novag S.A., Barcelona, Spain

    Adolfo Ga de Tiedra, Joan Mercadal &  Rafael Lozano

  2. Institut Universitari de Salud Pública de Catalunya Pavelló Central, Universitat de Barcelona, Barcelona, Spain

    Xavier Badía

  3. Servicio de Dermatología, Hospital Clínic i Provincial, Cátedra de Dermatología, Universidad de Barcelona, Barcelona, Spain

    José Ma Mascaró

Authors
  1. Adolfo Ga de Tiedra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joan Mercadal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xavier Badía
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. José Ma Mascaró
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rafael Lozano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rafael Lozano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Tiedra, A.G., Mercadal, J., Badía, X. et al. A Method to Select an Instrument for Measurement of HR-QOL for Cross-Cultural Adaptation Applied to Dermatology. Pharmacoeconomics 14, 405–422 (1998). https://doi.org/10.2165/00019053-199814040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199814040-00007

Keywords

Search

Navigation